BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 19017430)

  • 1. Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis.
    Mason O; Morgan CJ; Dhiman SK; Patel A; Parti N; Patel A; Curran HV
    Psychol Med; 2009 Jun; 39(6):951-6. PubMed ID: 19017430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines.
    Kuepper R; Morrison PD; van Os J; Murray RM; Kenis G; Henquet C
    Schizophr Res; 2010 Aug; 121(1-3):107-17. PubMed ID: 20580531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of cannabis use, psychotic-like experiences and personality styles in young cannabis users.
    Spriggens L; Hides L
    Schizophr Res; 2015 Jun; 165(1):3-8. PubMed ID: 25868934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing evidence supporting cannabis harm reduction practices for adolescents at clinical high-risk for psychosis: a review and clinical implementation tool.
    Kapler S; Adery L; Hoftman GD; Amir CM; Grigoryan V; Cooper ZD; Bearden CE
    Psychol Med; 2024 Jan; 54(2):245-255. PubMed ID: 37882050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis.
    Malcolm CP; Picchioni MM; DiForti M; Sugranyes G; Cooke E; Joseph C; McQueen G; Paparelli A; Stilo S; O'Connor J; Morgan C; Murray RM; Hodgins S
    Schizophr Res; 2011 Mar; 126(1-3):81-6. PubMed ID: 21186097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between the ZNF804A gene and cannabis use on the risk of psychosis in a non-clinical sample.
    Soler J; Arias B; Moya J; Ibáñez MI; Ortet G; Fañanás L; Fatjó-Vilas M
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():174-180. PubMed ID: 30118824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in cannabis use in the general population: a longitudinal study on the impact on psychotic experiences.
    van Gastel WA; Vreeker A; Schubart CD; MacCabe JH; Kahn RS; Boks MP
    Schizophr Res; 2014 Aug; 157(1-3):266-70. PubMed ID: 24930951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use and vulnerability for psychosis in early adolescence--a TRAILS study.
    Griffith-Lendering MF; Wigman JT; Prince van Leeuwen A; Huijbregts SC; Huizink AC; Ormel J; Verhulst FC; van Os J; Swaab H; Vollebergh WA
    Addiction; 2013 Apr; 108(4):733-40. PubMed ID: 23216690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychiatric complications of cannabis use].
    Coscas S; Benyamina A; Reynaud M; Karila L
    Rev Prat; 2013 Dec; 63(10):1426-8. PubMed ID: 24579344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.
    D'Souza DC; Ganesh S; Cortes-Briones J; Campbell MH; Emmanuel MK
    Psychol Med; 2020 Oct; 50(14):2452-2459. PubMed ID: 31615592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis use and risk of psychosis: an etiological link?
    Verdoux H; Tournier M
    Epidemiol Psichiatr Soc; 2004; 13(2):113-9. PubMed ID: 15298320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a common vulnerability in cannabis phenomenology and schizotypy? The role of the N170 ERP.
    Brooks GA; Brenner CA
    Schizophr Res; 2018 Jul; 197():444-450. PubMed ID: 29174334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults.
    McGrath J; Welham J; Scott J; Varghese D; Degenhardt L; Hayatbakhsh MR; Alati R; Williams GM; Bor W; Najman JM
    Arch Gen Psychiatry; 2010 May; 67(5):440-7. PubMed ID: 20194820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
    McHugh MJ; McGorry PD; Yung AR; Lin A; Wood SJ; Hartmann JA; Nelson B
    Psychol Med; 2017 Mar; 47(4):616-626. PubMed ID: 27821204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort.
    Stirling J; Barkus EJ; Nabosi L; Irshad S; Roemer G; Schreudergoidheijt B; Lewis S
    Psychopathology; 2008; 41(6):371-8. PubMed ID: 18787359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of metacognitive beliefs in the proneness to hallucinations and delusions: an analysis across clinical and non-clinical populations.
    Goldstone E; Farhall J; Thomas N; Ong B
    Br J Clin Psychol; 2013 Sep; 52(3):330-46. PubMed ID: 23865408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
    Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
    J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis use and psychosis: re-visiting the role of childhood trauma.
    Houston JE; Murphy J; Shevlin M; Adamson G
    Psychol Med; 2011 Nov; 41(11):2339-48. PubMed ID: 21557896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
    Arnold C; Allott K; Farhall J; Killackey E; Cotton S
    Schizophr Res; 2015 Oct; 168(1-2):231-7. PubMed ID: 26260081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.